🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate safety and efficacy of risankizuma...
Status
Active Not Recruiting
Location
Southern California Res. Ctr. /ID# 169659
Start Date
2018-08-28
Trial ID
NCT03398135
Treatments Being Tested
The objective of this registry is to compare outcomes of risankizumab-expos...
Status
Recruiting
Location
Evidera, a PPD Business Unit /ID# 238688
Start Date
2021-07-30
Trial ID
NCT04846959
Treatments Being Tested
Crohn's disease (CD) is an incurable chronic inflammatory disorder of the g...
Status
Recruiting
Location
Ospedale Specializzato In Gastroenterologia Saverio De Bellis /ID# 275706
Start Date
2025-07-14
Trial ID
NCT07073079
The purpose of this study is to assess how well guselkumab works when compa...
Status
Recruiting
Location
Digestive Health Specialists of the Southeast
Start Date
2026-04-21
Trial ID
NCT07499232
Treatments Being Tested
The purpose of the study is to compare the efficacy of bimekizumab versus r...
Status
Completed
Location
Pa0016 50662
Start Date
2024-10-21
Trial ID
NCT06624228
Treatments Being Tested
Plaque Psoriasis is a chronic inflammatory disease in which skin cells buil...
Status
Completed
Location
Inje University - Busan Paik Hospital /ID# 238911
Start Date
2020-08-04
Trial ID
NCT04433442
Psoriasis (PsO) is a chronic, disease characterized by marked inflammation ...
Status
Completed
Location
National Taiwan University Hospital /ID# 230017
Start Date
2021-05-31
Trial ID
NCT04818385
The purpose of this study is to assess the tissue distribution of guselkuma...
Status
Terminated
Location
Medical University Graz
Start Date
2021-11-04
Trial ID
NCT05083078
Treatments Being Tested
This is an open-label extension (OLE) study to assess the efficacy, safety ...
Status
Completed
Location
Multiple Locations
Start Date
2016-12-15
Trial ID
NCT02986373
Treatments Being Tested
The IMMagine study aims to validate the newly developed CLCI instrument (De...
Status
Completed
Location
Universite Libre de Bruxelles - Hopital Erasme /ID# 252456
Start Date
2023-11-09
Trial ID
NCT05959070